NasdaqCM - Delayed Quote USD

Prenetics Global Limited (PRENW)

0.0139
+0.0040
+(40.40%)
At close: May 21 at 4:00:00 PM EDT
Loading Chart for PRENW
  • Previous Close 0.0099
  • Open 0.0092
  • Bid --
  • Ask --
  • Day's Range 0.0092 - 0.0140
  • 52 Week Range 0.0092 - 0.0140
  • Volume 200,790
  • Avg. Volume --
  • Market Cap (intraday) --
  • Beta (5Y Monthly) -0.26
  • PE Ratio (TTM) --
  • EPS (TTM) -11.0410
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Prenetics Global Limited, a consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally. The company operates in three segments: Prevention, Diagnostics, and Consumer Health. It operates IM8 Health that sells health and wellness products; and provides fulfillment and distribution services for sports nutrition products under the Consumer Health segment. The company is also involved in the operation of CircleDNA, a consumer genetic testing brand that uses next-generation sequencing (NGS) technology to provide comprehensive insights into health, wellness, and genetic predispositions under Prevention segment.; and ACT Genomics that provides precision oncology testing services under the Diagnostics segment. In addition, it develops and commercializes multi-cancer early detection technologies. Further, the company offers a range of genomic profiling panels tailored for requirements and clinician needs. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.

www.prenetics.com

285

Full Time Employees

--

Fiscal Year Ends

Recent News: PRENW

View More

Compare To: PRENW

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PRENW

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -151.22%

  • Return on Assets (ttm)

    -13.50%

  • Return on Equity (ttm)

    -26.12%

  • Revenue (ttm)

    30.62M

  • Net Income Avi to Common (ttm)

    -46.33M

  • Diluted EPS (ttm)

    -11.0410

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.38M

  • Total Debt/Equity (mrq)

    3.37%

  • Levered Free Cash Flow (ttm)

    -9.9M

Research Analysis: PRENW

View More

Company Insights: PRENW

Research Reports: PRENW

View More

People Also Watch